May 13, 2021 07:14 AM EDTUpdated 07:32 AM
Coronavirus

Covid-19 roundup: Study finds that mix­ing Covid-19 vac­cines could lead to more fre­quent side ef­fects; CDC ad­comm votes unan­i­mous­ly in fa­vor of Pfiz­er/BioN­Tech shot in ado­les­cents

Nicole DeFeudis

Editor

Fol­low­ing re­ports of blood clots with low platelets, coun­tries like Den­mark are rec­om­mend­ing that those who got their first As­traZeneca shot should re­ceive a dif­fer­ent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times